| Company |
New Filing? |
Reported funding |
Incremental Cash |
Date |
New or Amended |
|
Tangen Biosciences, Inc.
(Biotechnology)
|
Yes |
$464,767 |
$464,767 |
2023-06-06 |
New Filing |
|
AKO EUROPEAN LONG-ONLY FUND LTD
(Pooled Investment Fund)
|
No |
$7,119,779,347 |
$160,559,408 |
2026-01-16 |
Amended |
|
AKO FUND LTD
(Pooled Investment Fund)
|
No |
$2,424,139,055 |
$18,850,000 |
2026-01-16 |
Amended |
|
AKO GLOBAL LONG-ONLY FUND LTD
(Pooled Investment Fund)
|
No |
$3,595,805,509 |
$144,071,400 |
2025-10-03 |
Amended |
|
AKO GLOBAL FUND LTD
(Pooled Investment Fund)
|
No |
$1,671,333,195 |
$0 |
2026-02-27 |
Amended |
|
AKO EUROPEAN LONG-ONLY PARTNERS L.P.
(Pooled Investment Fund)
|
No |
$1,526,295,835 |
$61,750,000 |
2026-01-16 |
Amended |
|
AKO PARTNERS L.P.
(Pooled Investment Fund)
|
No |
$2,193,446,854 |
$44,720,000 |
2026-01-16 |
Amended |
|
North Shoreline Ventures I LLC
(Pooled Investment Fund)
|
Yes |
$2,440,207 |
$2,440,207 |
2017-06-30 |
New Filing |
|
North Shoreline Ventures III LLC
(Pooled Investment Fund)
|
Yes |
$199,998 |
$199,998 |
2018-02-28 |
New Filing |
|
North Shoreline Ventures IV LLC
(Pooled Investment Fund)
|
Yes |
$750,000 |
$750,000 |
2018-03-09 |
New Filing |